2-(2,3-Dihydro-1H-1,3-benzodiazol-2-ylidene)-4,4-dimethyl-3-oxopentanenitrile

Catalog No. :
ACJLIA250
CAS No. :
158262-74-9
Molecular Formula :
C14H15N3O
Molecular Weight :
241.29

IUPAC Name:2-(1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-4,4-dimethyl-3-oxopentanenitrile

2-(2,3-Dihydro-1H-1,3-benzodiazol-2-ylidene)-4,4-dimethyl-3-oxopentanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg90%$121.00Login to see priceInquiryInquiry
10mg90%$148.00Login to see priceInquiryInquiry
50mg90%$208.00Login to see priceInquiryInquiry
100mg90%$274.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,3-Dihydro-1H-1,3-benzodiazol-2-ylidene)-4,4-dimethyl-3-oxopentanenitrile
IUPAC Name2-(1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-4,4-dimethyl-3-oxopentanenitrile
Molecular FormulaC14H15N3O
Molecular Weight241.29
SMILESCC(C)(C)C(=O)C(C#N)=C1NC2=CC=CC=C2N1
InChI KeyDSUCFHILNUWEEL-UHFFFAOYSA-N
Synonym2-(3-HYDROBENZIMIDAZOL-2-YLIDENE)-4,4-DIMETHYL-3-OXOPENTANENITRILE;2-(1,3-dihydrobenzimidazol-2-ylidene)-4,4-dimethyl-3-oxopentanenitrile;AURORA 13820;2-(2,3-dihydro-1H-1,3-benzodiazol-2-ylidene)-4,4-dimethyl-3-oxopentanenitrile;Pentanenitrile, 2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-4,4-dimethyl-3-oxo-
CAS No.158262-74-9

Synthetic Route by SureRoute

1. ACJLIA250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLIA250 route product structure diagram
    ACJLIA250158262-74-9
Inquiry

2. ACJLIA250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLIA250 route product structure diagram
    ACJLIA250158262-74-9
Inquiry

Comments (0)